Gann helps identify patterns early on. Before the end of this week, we'll have short term direction. Buy the dip, or sell the rally? 1.760% revenue increase, and not a single penny up? Ridiculous! This is a stock that is getting way to little attention. Wait until it gets the two licenses granted, later this year! ALEF has more capacity than CRON, just a little less than HEXO. Aleafia is the seventh largest producer, and with medical focus and client base, they don't care about the Canadian recreational market. Supply deal with CannTrust, good international footprint. Find your entries now, and enjoy the returns when the rest of the world wakes up the ALEF's potential.
Comment
⋅
This is a perfect bounce on the 45 degree Gann line. The worst may be behind us yet.
I am amazed that it didnt move with the earnings. Getting way too little attention from the investors